TOVX

TOVX P/E Ratio
P/E Ratio as of Oct 27, 2026: -0.28
Average-0.3168
Median-0.3200
Minimum-0.3500
Maximum-0.2800
-0.28
0.05 (15.15%)past month
The P/E ratio for TOVX is -0.28 as of Oct 27, 2026. This represents a increase of 75.00% compared to its 12-month average P/E ratio of -0.16. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Theriva Biologics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Theriva Biologics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Theriva Biologics Inc to industry peers.
Theriva Biologics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Theriva Biologics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Theriva Biologics Inc to industry peers.
TOVX P/E Ratio Insights
See Theriva Biologics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TOVX
Order type
Buy in
Order amount
Est. shares
0 shares
TOVX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $0.225 | -0.34 |
| Sep 1, 2026 | $0.249 | -0.37 |
| Aug 3, 2026 | $0.2227 | -0.33 |
| Jul 1, 2026 | $0.2506 | -0.37 |
| Jun 1, 2026 | $0.282 | -0.11 |
| May 1, 2026 | $0.3896 | -0.15 |
| Apr 1, 2026 | $0.2266 | -0.09 |
| Mar 2, 2026 | $0.1987 | -0.05 |
| Feb 2, 2026 | $0.178 | -0.04 |
| Jan 2, 2026 | $0.258 | -0.06 |
TOVX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.28 | +600.00% |
| 2025 | -0.04 | -20.00% |
| 2024 | -0.05 | -86.11% |
| 2023 | -0.36 | +5.88% |
| 2022 | -0.34 | -73.23% |
| 2021 | -1.27 | — |
FAQs About Theriva Biologics Inc (TOVX) P/E ratio
The latest P/E ratio of TOVX is -0.28, as of Oct 27, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Theriva Biologics Inc’s last 12-month average P/E ratio is -0.16, compared to its current P/E ratio of -0.28. This reflects a increase of 75.00%.
Theriva Biologics Inc’s current P/E ratio of -0.28 is higher than its last 12-month average P/E of -0.16. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Theriva Biologics Inc’s average P/E ratio over the last 3 years is -0.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Theriva Biologics Inc’s average P/E ratio over the last 5 years is -0.5. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
TOVX P/E Ratio Insights
See Theriva Biologics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TOVX
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.